Cited by 357Rheumatoid Arthritis Research and TherapiesInflammatory mediators and NSAID effectsGout, Hyperuricemia, Uric Acid

The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., Edwards, C. J.·2010·Rheumatology

DOI 10.1093/rheumatology/kep366

Open this paper in CoChat — free account

Abstract

OBJECTIVES: Patients with RA have an increased prevalence of cardiovascular disease (CVD). This is due to traditional risk factors and the effects of chronic inflammation. MTX is the first-choice DMARD in RA. We performed a systematic literature review to determine whether MTX affects the risk of CVD in patients with RA. METHODS: We searched Medline, Embase, Cochrane database, database of abstracts of reviews of effects, health technology assessment and Science Citation Index from 1980 to 2008. Conference proceedings (British Society of Rheumatology, ACR and EULAR) were searched from 2005 to 2008. Papers were included if they assessed the relationship between MTX use and CVD in patients with RA. Two reviewers independently assessed each title and abstract for relevance and quality. RESULTS: A total of 2420 abstracts were identified, of which 18 fulfilled the inclusion criteria. Two studies assessed the relationship between MTX use and CVD mortality, one demonstrated a significant reduction in CVD mortality and the second a trend towards reduction. Five studies considered all-cause CVD morbidity. Four demonstrated a significant reduction in CVD morbidity and the fifth a trend towards reduction. MTX use in the year prior to the development of RA decreased the risk of CVD for 3-4 years. Four studies considered myocardial infarction, one demonstrated a decreased risk and three a trend towards decreased risk with MTX use. CONCLUSION: The current evidence suggests that MTX use is associated with a reduced risk of CVD events in patients with RA. This suggests that reducing the inflammation in RA using MTX not only improves disease-specific outcomes but may also reduce collateral damage such as atherosclerosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/rheumatology/kep366

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Being big or growing fast: systematic review of size and growth in infancy and later obesity
Baird, J., Fisher, D., Lucas, P., Kleijnen, J., Roberts, H., & Law, C. (2005) · BMJ · doi:10.1136/bmj.38586.411273.e0 · Cited by 1,185
Self-citation
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. Á., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,133
Cardiovascular Risk and Inhibition of Cyclooxygenase
McGettigan, P., & Henry, D. A. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,106
Cardiovascular death in rheumatoid arthritis: A population‐based study
Kremers, H. M., Nicola, P., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 941
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N. A., McCarey, D. W., Capell, H. A., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 932
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E., Coblyn, J. S., Fox, D. A., Fraser, P. A., Holdsworth, D. E., Glass, D. N., & Trentham, D. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121303 · Cited by 872
Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?
Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645

Show all 57 references

Research works printed but not linked: 11

Symmons, 1998, The Journal of Rheumatology, 25, 1072
1985, CLINICAL AND IMMUNOLOGIC EFFECTS IN A RANDOMIZED DOUBLEBLIND STUDY ANN INTERN MED, 103, 489
1985, A CONTROLLED CLINICAL TRIAL ARTHRITIS RHEUM, 28, 721
Thompson, 1984, The Journal of Rheumatology, 11, 760
2008, Rheumatology, 47, ii49
2006, Annals of the Rheumatic Diseases, 65, 307
2008, Arthritis and rheumatism, 56, 688
2007, Arthritis and rheumatism, 56, S293
GOODSON, 2008, The Journal of Rheumatology, 35, 945
Seriolo, 2008, Clinical and experimental rheumatology, 26, 159
Morgan, 1998, The Journal of Rheumatology, 25, 441

Sorted by citations

Items 201–300 of 357

New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment
Kim, H. W., Han, M., Jung, I., & Ahn, S. S. (2023) · Lara D. Veeken · doi:10.1093/rheumatology/kead336 · Cited by 14
Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link
Bartoloni, E., Alunno, A., Luccioli, F., Moscatelli, S., Biscontini, D., Santoboni, G., & Gerli, R. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.123 · Cited by 14
Profil lipidique et risque cardiovasculaire chez les patients atteints de polyarthrite rhumatoïde : influence de la maladie et de la thérapeutique médicamenteuse
Hansel, B., & Bruckert, É. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.03.005 · Cited by 14
Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials
Thanigaimani, S., Phie, J. K. P., Krishna, S. M., Moxon, J. V., & Golledge, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-86128-y · Cited by 14
Low Levels of CD36 in Peripheral Blood Monocytes in Subclinical Atherosclerosis in Rheumatoid Arthritis: A Cross-Sectional Study in a Mexican Population
Gómez-Bañuelos, E., Martín-Márquez, B. T., Martínez-García, E. A., Figueroa-Sanchez, M., Núñez-Atahualpa, L., Rocha-Muñoz, A. D., Sánchez‐Hernández, P. E., Navarro-Hernández, R. E., Madrigal-Ruiz, P. M., Saldaña-Millan, A., et al. (2014) · BioMed Research International · doi:10.1155/2014/736786 · Cited by 14
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention
Forzano, I., Florimonte, D., Narciso, V., Canonico, M. E., Castiello, D. S., Manzi, L., Cristiano, S., Spinelli, A. M., Vallone, D. M., D’Alconzo, D., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238334 · Cited by 17
Assessment of hemostatic disturbances in women with established rheumatoid arthritis
Vranić, A., Pruner, I., Veselinović, M., Soutari, N. M. H., Petković, A., Jakovljevic, V. L., & Antovič, A. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04629-8 · Cited by 13
Prevalence and Risk Factors of Cardiovascular Disease in Rheumatoid Arthritis Patients: A Comparative Analysis of Real-World Data
Tekeoğlu, S. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s490916 · Cited by 12
The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids
Sepehrifar, M. B., Karimifar, M., Moussavi, H., Sepehrifar, M. B., Mottaghi, P., Siavash, M., & Karimifar, M. (2018) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_869_17 · Cited by 12
Framework of treating Alzheimer’s dementia
Yang, Y., Liščić, R. M., & Dominguez, J. C. (2019) · Brain Science Advances · doi:10.1177/2096595820902580 · Cited by 12
Key Roles of Inflammation in Atherosclerosis: Mediators Involved in Orchestrating the Inflammatory Response and Its Resolution in the Disease Along with Therapeutic Avenues Targeting Inflammation
Chan, Y., & Ramji, D. P. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_2 · Cited by 13
Cardiac magnetic resonance assessment of cardiac involvement in autoimmune diseases
Gulhane, A., & Ordovas, K. G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1215907 · Cited by 11
Inflammatory cell infiltrates in the heart of patients with coronary artery disease with and without inflammatory rheumatic disease: a biopsy study
on behalf of the Feiring Heart Biopsy Study Group, Andersen, J. K., Oma, I., Prayson, R. A., Kvelstad, I. L., Almdahl, S. M., Fagerland, M. W., & Hollan, I. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1136-5 · Cited by 11
Terapias antiinflamatorias para la enfermedad cardiovascular: vías de señalización y mecanismos
Martínez‐Hervás, S., & Navarro, H. G. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.02.022 · Cited by 11
Strategien zur verbesserten Versorgung von Menschen mit der Volkskrankheit „Rheuma“ am Beispiel der rheumatoiden Arthritis
Kalden, J. R., Burkhardt, H., Buß, B., Donhauser-Gruber, U., Erstling, U., Gromnica‐Ihle, E., Karberg, K., Karger, T., Kneitz, C., Krause, A., et al. (2011) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0763-0 · Cited by 10
Methotrexate use, not interleukin 33, is associated with lower carotid intima-media thickness in patients with rheumatoid arthritis
Pinto, M. R. D. C., Kakehasi, A. M., Souza, A. J., Tavares, W. C., Rocha, M. A., Trant, C. G. M. C., & de Andrade, M. V. M. (2019) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-019-0060-1 · Cited by 10
Patients With Rheumatoid Arthritis With an Inadequate Response to Disease‐Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome
Hsu, C., Su, Y., Chen, J., Sun, C., Cheng, T., Tsai, T., Lin, S., Chang, C., & Chen, T. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018290 · Cited by 9
Implicaciones clínicas, diagnósticas y terapéuticas de la psoriasis y enfermedad cardiovascular
Bonanad, C., González‐Parra, E., Rivera, R., Carrascosa, J. M., Daudén, E., Olveira, A., & Estrada, R. B. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2016.12.023 · Cited by 10
A TEN YEAR OVERVIEW OF SURGICAL AND INTERVENTIONAL ARRHYTHMOLOGY IN RUSSIA. SERVICE PECULIAR FEATURES IN THE FAR EAST
Богачевская, С. А., & Николаевич, Б. А. (2017) · Social Aspects of Population Health · doi:10.21045/2071-5021-2017-53-1-1 · Cited by 10
Managing premature atherosclerosis in patients with chronic inflammatory diseases
Legge, A. C., & Hanly, J. G. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170776 · Cited by 9
Pharmacological Effects of Methotrexate and Infliximab in a Rats Model of Diet-Induced Dyslipidemia and Beta-3 Overexpression on Endothelial Cells
Zălar, D.-M., Pop, C., Buzdugan, E., Kiss, B., Ștefan, M.-G., Ghibu, S., Bâlteanu, V.-A., Crişan, D., Buruiană, A., Grozav, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143143 · Cited by 12
Chronic inflammation-enhanced atherosclerosis: Can we consider it as a new clinical syndrome?
Kucharz, E. J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.11.020 · Cited by 9
Targeted anti-inflammatory therapy is a new insight for reducing cardiovascular events: A review from physiology to the clinic
Soroureddin, Z., Nouri‐Vaskeh, M., Maleki, M., Baghbanzadeh, A., Hajiasgharzadeh, K., Sadeghi, M. T., & Baradaran, B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117720 · Cited by 9
When Randomized Clinical Trials and Real‐World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety
Kim, S. C., & Schneeweiß, S. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41092 · Cited by 9
Cardio-Rheumatology Insights Into Hypertension: Intersection of Inflammation, Arteries, and Heart
Akhtari, S., Harvey, P., & Eder, L. (2024) · American Journal of Hypertension · doi:10.1093/ajh/hpae098 · Cited by 8
Impact of NSAIDs corticosteroids DMARDs biologics and their comparisons with natural products in C-reactive proteins (CRP) linked cardiovascular disorders
Satapathy, T., Minj, A., & Verma, M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01767-1 · Cited by 11
Understanding cardiovascular risk in rheumatoid arthritis: Still a long way to go
Gualtierotti, R. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.009 · Cited by 8
Cardiovascular Risk of Synthetic, Non-Biologic Disease-Modifying Anti- Rheumatic Drugs (DMARDs)
Mourouzis, I. S., Manolis, A. S., & Pantos, C. I. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190930113837 · Cited by 8
Values and Correlations between C-Reactive Protein and Apolipoprotein B after Treatment with Methotrexate at Patients with Rheumatoid Arthritis
Ismaili, H., Ismaili, L., & Rexhepi, M. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.278 · Cited by 8
Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta-analysis
Shi, A., Shu, Y., Haddad, J. E., Wu, S., Smayra, K., Sudesh, S. M., Mourad, M. M., Farzad, A., Yap, N., Andrikopoulou, E., et al. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01472-5 · Cited by 7
The specialist physician’s approach to rheumatoid arthritis in South Africa
Bester, F. C. J., Bosch, F. J., & van Rensburg, B. J. J. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.134 · Cited by 7
Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
Hloch, K., Doseděl, M., Tebbens, J. D., Žaloudková, L., Medkova, H. K., Vlček, J., Soukup, T., & Pávek, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.703279 · Cited by 7
METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
Nasonov, E. L. (2015) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2015-64-76 · Cited by 7
Non-Fas(CD95/APO1)-mediated apoptosis of activated T cells inhibits the development of atherosclerosis
Esparza, L., Haro, J. D., Bleda, S., & Acín, F. (2012) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivs123 · Cited by 7
Rheumatoid arthritis: some components of hemostasis and inflammation
Cheldieva, F. A., & Reshetnyak, T. M. (2019) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2019-3-87-94 · Cited by 7
Examining the Risk of Cardiovascular Disease in Patients with Psoriasis: A Critical Review
Papp, K. A., Poulin, Y. P., & Vieira, A. (2013) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2012.11126 · Cited by 6
Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis
Zhang, F., Han, L., Wang, B., Huang, Q., Yawalkar, N., Zhang, Z., & Yan, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237059 · Cited by 6
Ethical considerations when prescribing biologics in dermatology
Santoro, F. A., Rothe, M. J., & Strober, B. E. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.06.018 · Cited by 6
Safe Use of Antirheumatic Agents in Patients with Comorbidities
Makol, A., Wright, K., & Matteson, E. L. (2012) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2012.08.013 · Cited by 6
Prescribing Trend of Antirheumatic Drugs in Taiwan and Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study
Lee, C.-Y., Tai, C., Tsai, Y.-F., Kuan, Y., Lee, C., & Huang, K. (2019) · BioMed Research International · doi:10.1155/2019/7987529 · Cited by 6
Degree of arterial stiffness is comparable across inflammatory joint disease entities
Föhse, K., Rollefstad, S., Ikdahl, E., Wibetoe, G., Sexton, J., Hisdal, J., & Semb, A. G. (2021) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2021.1920169 · Cited by 6
Identifying and managing psoriasis-associated comorbidities: the IMPACT research programme
Cordingley, L., Nelson, P. A., Davies, L. M., Ashcroft, D. M., Bundy, C., Chew-Graham, C. A., Chisholm, A., Elvidge, J., Hamilton, M., Hilton, R., et al. (2022) · Programme Grants for Applied Research · doi:10.3310/lvuq5853 · Cited by 6
Methotrexate
Johnsen, A. K., & Weinblatt, M. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00056-5 · Cited by 6
Rheumatoid arthritis and heart disease: the chicken and the egg?
Crowson, C. S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02296.x · Cited by 6
Smoking and rheumatoid arthritis
Litwic, A., & Edwards, C. J. (2013) · doi:10.2217/ebo.12.170 · Cited by 6
Self-citation
Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study
Lam, T. T., Cheng, I. T., Lam, S. H. M., Mok, C. C., Ho, C. T. K., Cheung, T. T., Lao, V. W. N., Pang, H. T., To, C. H., Yim, C. W., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/kead039 · Cited by 6
Polymyalgia Rheumatica
Bartoloni, E., Pucci, G., Alunno, A., Gerli, R., & Schillaci, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00009-0 · Cited by 5
Important issues at heart: cardiovascular risk management in rheumatoid arthritis
Roubille, C., & Haraoui, B. P. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x13491853 · Cited by 5
Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis
Raczkiewicz, A., Juszkiewicz, A., Kisiel, B. M., Bachta, A., Kur‐Zalewska, J., Klos, K., Bujakowska, O., Tłustochowicz, M., & Tłustochowicz, W. (2016) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2016.60225 · Cited by 4
Effectiveness of methotrexate therapy with occasional corticosteroid in rheumatoid arthritis
Patel, S. L., Kumar, V., Mishra, R., Chandra, V., Negi, M. P. S., Tripathy, B. C., Prakash, J., & Gupta, V. (2015) · Current Orthopaedic Practice · doi:10.1097/bco.0000000000000213 · Cited by 4
An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches
Herrinton, L. J., Ray, G. T., Curtis, J. R., Wu, J. J., FIREMAN, B. H., Liu, L., & Goldfien, R. D. (2018) · The Permanente Journal · doi:10.7812/tpp/17-101 · Cited by 4
Methotrexate and Cardiovascular Disease in Patients With Rheumatoid Arthritis: Insights and Novel Speculations
Kremer, J. M. (2021) · The Journal of Rheumatology · doi:10.3899/jrheum.201415 · Cited by 4
The impact of diabetes mellitus on treatment and outcomes of rheumatoid arthritis at 5-year follow-up: results from a multi-ethnic Asian cohort
Xu, C., Yong, M. Y., Koh, E. T., Dalan, R., Leong, K. P., and the TTSH Rheumatoid Arthritis Study Group, Ang, A., Chan, A. L.-H., Chan, G. Y. L., Chan, M. T.-L., et al. (2021) · Rheumatology Advances in Practice · doi:10.1093/rap/rkab077 · Cited by 4
Rosuvastatin induced carotid plaque regression in patients with inflammatory joint diseases
Rollefstad, S., Ikdahl, E., Hisdal, J., Holme, I., Olsen, I. C., Smerud, K. T., Pedersen, T. R., Kvien, T. K., & Semb, A. G. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.248 · Cited by 4
Long-Term Outcomes in Puerto Ricans with Rheumatoid Arthritis (RA) Receiving Early Treatment with Disease-Modifying Anti-Rheumatic Drugs using the American College of Rheumatology Definition of Early RA
Varela-Rosario, N., Arroyo-Ávila, M., Fred-Jiménez, R. M., Díaz-Correa, L. M., Pérez-Ríos, N., Rodríguez, N., Ríos, G., & Vilá, L. M. (2017) · The Open Rheumatology Journal · doi:10.2174/1874312901711010136 · Cited by 4
Entzündungsbedingte kardiovaskuläre Morbidität
Fischer‐Betz, R., Halle, M., & Schneider, M. (2010) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-009-0585-5 · Cited by 4
Exploring Priority Research Areas in Psoriasis and Psoriatic Arthritis from Dermatologists’ Perspective: A Report from the GRAPPA 2011 Annual Meeting
Armstrong, A. W., Duffin, K. C., Garg, A., Gelfand, J. M., Gottlieb, A. B., Krueger, G. G., Qureshi, A. A., & Rosen, C. F. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.120825 · Cited by 4
Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease
Bonanad, C., González‐Parra, E., Rivera, R., Carrascosa, J. M., Daudén, E., Olveira, A., & Estrada, R. B. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2017.08.021 · Cited by 4
Cardiovascular Risk in Autoimmune Diseases: Mechanisms, Management, and Emerging Evidence
Baloch, M. B., Alphonse, C., Baldev, N., Nin-Arroyo, G. M., Keezhath, R., Behara, A., Khurana, S., Nwokeji, S., Imam, B., & Abarca, Y. A. (2025) · Cureus · doi:10.7759/cureus.91897 · Cited by 3
Immunomodulatory properties of a methanolic extract of Ficus lyrata mitigate inflammation in Complete Freund’s Adjuvant-induced arthritis
Iftikhar, A., Saleem, M., Raza, S. A., Achuthan, A. A., Luwor, R. B., Muhammad, T., & Majeed, U. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01700-6 · Cited by 3
Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study
Karpouzas, G. A., Ormseth, S. R., van Riel, P. L. C. M., Myasoedova, E., González-Gay, M. Á., Corrales, A. R., Rantapää‐Dahlqvist, S., Sfikakis, P. P., Dessein, P. H., Hitchon, C. A., et al. (2025) · Rheumatology International · doi:10.1007/s00296-025-05838-y · Cited by 3
Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases
Wibetoe, G., Ikdahl, E., Rollefstad, S., Olsen, I. C., Bergsmark, K., Kvien, T. K., Salberg, A., Soldal, D. M., Bakland, G., Lexberg, Å. S., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.10.038 · Cited by 3
Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A
Lakota, K., Hrušovar, D., Ogrič, M., Mrak‐Poljšak, K., Čučnik, S., Tomšič, M., Božič, B., Žigon, P., & Sodin-Semrl, S. (2018) · Mediators of Inflammation · doi:10.1155/2018/8237209 · Cited by 3
Protocol for rheumatoid arthritis complicated with cardiovascular damage treated with Guanxining tablet with a randomized controlled trial
Yu, K., Yang, K., Han, T., Sun, Q., Zhu, M., Wang, X., & Wang, W. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19241 · Cited by 3
Anti-inflammatory therapy in the treatment of cardiovascular diseases
Tomaniak, M., & Filipiak, K. J. (2015) · Kardiologia Polska · doi:10.5603/kp.a2015.0191 · Cited by 3
Benefits of Fish Oil for Rheumatoid Arthritis
Dawczynski, C., & Jahreis, G. (2011) · CRC Press eBooks · doi:10.1201/b10852-30 · Cited by 3
Methotrexate: Cirt Ified for Preventing Atherosclerotic Events?
Pandey, A., & Goyal, M. (2019) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2019.211 · Cited by 3
The initial treatment strategy and the long-term outcome of early rheumatoid arthritis with special interest in the FIN-RACo trial and the current Finnish practice
Rantalaiho, V. M. (2012) · Tampere University Institutional Repository (Tampere University) · Cited by 3
High-dose folic acid supplement is associated with increased cardiovascular risk in rheumatoid arthritis patients on methotrexate
Meng, H., So, H., Yan, X., Jin, Y., Lam, S. H. M., Kwok, T., & Tam, L. (2026) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x261423837 · Cited by 3
Anti-inflammatory therapy in atherosclerotic cardiovascular disease: Current reappraisal
Muduli, S. K., Gupta, M. D., Girish, M. P., & Yadav, R. K. (2023) · Indian Heart Journal · doi:10.1016/j.ihj.2023.10.007 · Cited by 3
Antirheumatic drugs and cardiovascular disease in rheumatoid arthritis
Szekanecz, Z., Szűcs, G., & Kerekes, G. (2023) · Rheumatology Forum · doi:10.5603/rf.2023.0010 · Cited by 2
Computational Approaches for Structure-Assisted Drug Discovery and Repurposing
Pandey, A. K., & Verma, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7123-3_9 · Cited by 3
Comparative Effectiveness of Anti-Hyperlipidemic Drugs Monotherapy in Primary Prevention of Cardiovascular Disease
Li, X., Steenhuis, D., Bijlsma, M. J., de Vos, S., Mubarik, S., Bos, J., Schuiling‐Veninga, C. C. M., & Hak, E. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s479120 · Cited by 2
Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate?
Bahadori, S., Ahmadzadeh, A., Ardekani, M. R. S., Kamalinejad, M., Keshavarz, M., & Salamzadeh, J. (2016) · PubMed Central · Cited by 2
The Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis Treated with Conventional DMARDs: a Clinic Based Case Control Study
Ибрагимов, К. Х., Sultonov, I. I., Исламова, К., Ахмедов, И., & Байсариев, Ш. (2022) · Кардиология в Беларуси · doi:10.34883/pi.2022.14.3.004 · Cited by 2
„Off label use“ von Methotrexat in der klinischen Rheumatologie
Briem, S. K., & Lorenz, H.-M. (2011) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-010-0685-2 · Cited by 2
An Anti-Inflammatory Approach in the Therapeutic Choices for the Prevention of Atherosclerotic Events
Pende, A., & Denegri, A. (2012) · InTech eBooks · doi:10.5772/31565 · Cited by 1
Europejskie wytyczne dotycza̧ce zapobiegania chorobom serca i naczyń w praktyce klinicznej na 2012 rok
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · Ghent University Academic Bibliography (Ghent University) · Cited by 2
Arterial Hypertension in Patients with Rheumatoid Arthritis. What should be known and considered at diagnosis and treatment?
Nikitina, N. M., Romanova, T. A., Афанасьев, И. А., Tyapkina, M. A., & Rebrov, A. P. (2016) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2016-12-5-547-552 · Cited by 2
Rheumatoid arthritis: influence of inflammation and anti-inflammatory therapy on cardiovascular risk factors
Трухан, Д. И., Ivanova, D. S., & Белус, К. Д. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-11-32-44 · Cited by 2
Protective Effect of Citrulline on the methotrexate - induced cardiac muscle toxicity in male albino rats: Histological and immunohistochemical study
Elsammak, G., Mostafa, S. A., & Reda, S. M. (2020) · Journal of Medical Histology/Journal of Medical Histology · doi:10.21608/jmh.2020.35314.1078 · Cited by 2
High-Sensitivity C-Reactive Protein
Feldman, D. I., Blumenthal, R. S., & Gluckman, T. J. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_17 · Cited by 2
Methotrexate in the treatment of rheumatic disease
Kanevskaya, M., & Gurskaya, S. V. (2013) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2013-2438 · Cited by 2
Role of Traditional Risk Factors, Inflammation and DMARDs in Cardiovascular Diseases in Rheumatoid Arthritis and Management of Lipid Profile
Aziz, M., & Yadav, K. S. (2016) · HAL · Cited by 2
Managing residual inflammatory risk in atherosclerotic cardiovascular disease: another piece of the puzzle?
Dai, Y., & Ge, J. (2022) · Cardiology Plus · doi:10.1097/cp9.0000000000000005 · Cited by 2
The Effects of Immunosuppressive and Cytotoxic Drugs on the Heart
Russell, S. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00026-0 · Cited by 1
Unravelling the Major Cardiovascular Risks of Systemic Psoriasis Medications: A Literature Systematic Review
Son, M. T. H., Biloa, Y. J. M., Gouttefarde, P., Franck, T., Cizeron, G., Oriol, M., Maccari, F., Cinotti, É., Trombert‐Paviot, B., Bongué, B., et al. (2025) · JEADV Clinical Practice · doi:10.1002/jvc2.70134 · Cited by 1
Cardiovascular risk in rheumatoid arthritis: when does it really start?
Nurmohamed, M. T. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.26 · Cited by 1
Smoking and comorbidities in rheumatoid arthritis: what we know and what we can do?
Zhao, S. S., & Goodson, N. J. (2015) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.14.55 · Cited by 1
The Relationship between Cardiovascular Disease and Inflammatory Arthritis, and the Potential Role of Exercise on the Burden of Illness: a Scoping Review
Petrella, J. A. M., Wolfe, D. L., & Petrella, R. J. (2013) · International Journal of Cardiovascular and Cerebrovascular Disease · doi:10.13189/ijccd.2013.010202 · Cited by 1
Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
Udachkina, E. V., Novikova, D. S., Попкова, Т. В., Panasyuk, E. Y., Avdeeva, A. S., Volkov, A. V., Геннадьевна, К. И., Markelova, E. I., Aleksandrova, E. N., Novikov, A. A., et al. (2015) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2015-11-5-510-516 · Cited by 1
Cardiovascular Risk in Inflammatory Rheumatic Disease
Gabriel, S. E., & Crowson, C. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00036-x · Cited by 1
Rheumatoid arthritis and atherosclerosis: common features in immunopathogenesis. Literature review
Palhuyeva, H. Y., Litvyakov, A. M., & Лагутчев, В. В. (2020) · Vestnik of Vitebsk State Medical University · doi:10.22263/2312-4156.2020.6.31 · Cited by 1
Sex-differential downregulation of methotrexate on plasma viscosity and whole blood viscosity in psoriasis
Han, L., Guo, M., Wang, B., Meng, Q., Zhu, J., Huang, Q., Zhang, Z., Fang, X., Yang, K., Wu, S., et al. (2022) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-211343 · Cited by 1
Inflammation and Cardiovascular Outcomes
Satish, P., & Agarwala, A. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_10 · Cited by 1
Management of rheumatoid arthritis in primary care
Perry, M. A. (2017) · Practice Nursing · doi:10.12968/pnur.2017.28.5.208 · Cited by 1
Long-term immunosuppressive therapy for inflammatory eye disease – the link between systemic treatment, cardiovascular risk and disease?
Yates, W., McCluskey, P., & Wakefield, D. (2017) · Expert Review of Ophthalmology · doi:10.1080/17469899.2017.1349610 · Cited by 1
Cardiovascular risk in rheumatoid arthritis.
Omelchenko, V. O., Korolev, M. A., Поспелова, Т. И., & Konenkov, V. I. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2018-96-6-491-497 · Cited by 1
High-Sensitivity C-Reactive Protein
David I. Feldman, Blumenthal, R. S., & Gluckman, T. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00008-x · Cited by 1
Artrite reumatoide: por que tratar apenas a artrite, sabendo que comorbidades são comuns e determinam morbidade e mortalidade?
Pereira, I. A. (2012) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042012000400001 · Cited by 1

Authors: Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J.
Affiliations: King's College London (GB)
ORCID: Baird, J.
Kiely, P.
Quinn, M.
Choy, E.
Venue: Rheumatology
Publisher: Oxford University Press (OUP)
Published: 2009-11-27
Volume: 49
Issue: 2
Pages: 295-307
ISSN: 1462-0324 (ISSN-L)
1462-0332
DOI: 10.1093/rheumatology/kep366
OpenAlex: W2100260684
Cited by: 357
References: 57
Citations by year: 2026: 5 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 15 · 2021: 18 · 2020: 15 · 2019: 26 · 2018: 20 · 2017: 25 · 2016: 32 · 2015: 38 · 2014: 25 · 2013: 33 · 2012: 42
FWCI: 3.66
Type: journal article
Language: en
Open access: closed
Locations: Lara D. Veeken (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (submittedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
Keywords: methotrexate, rheumatoid arthritis, cardiovascular disease, cardiovascular mortality, cardiovascular morbidity, myocardial infarction, atherosclerosis, disease-modifying antirheumatic drugs, chronic inflammation
MeSH terms: Arthritis, Rheumatoid, Cardiovascular Diseases, Humans, Immunosuppressive Agents, Insulin Resistance, Lipids, Methotrexate, Antirheumatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks